Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies.

Efstathios KastritisFoteini TheodorakakouIoannis-Ntanasis StathopoulosVassiliki SpiliopoulouEirini SoliaPanagiotis MalandrakisRodanthi SyrigouNikoleta KokkaliMagdalini MigkouEvangelos Eleutherakis-PapaiakovouDespina FotiouMaria RoussouNikolaos KanelliasMaria GavriatopoulouEvangelos TerposMeletios A Dimopoulos

Published in: HemaSphere (2023)

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
metabolic syndrome
skeletal muscle
nk cells